Haemonetics Corp (NYSE:HAE)

88.13
Delayed Data
As of 4:00pm ET
 -1.45 / -1.62%
Today’s Change
72.26
Today|||52-Week Range
95.26
+12.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues241.6M247.4M249.3M238.5M
 
 
 
 
 
Cost of Goods Sold100.0M103.4M103.5M95.1M
 
 
 
 
 
Depreciation And Amortization25.3M27.9M29.8M27.4M
 
 
 
 
 
 
Operating ExpensesGross Income116.3M116.0M116.0M115.9M
 
 
 
 
 
General Expenses83.8M81.1M81.0M80.5M
 
 
 
 
 
Research And Development8.6M9.0M8.7M7.5M
 
 
 
 
 
Total Operating Expenses209.1M212.4M214.3M203.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income32.5M34.9M35.0M35.4M
 
 
 
 
 
Extraordinary Credit255.0K131.0K300.0K--
 
 
 
 
Extraordinary Charge-6.6M-6.6M-11.2M-48.7M
 
 
 
 
 
Interest Expense On Debt3.3M3.0M2.1M4.4M
 
 
 
 
 
Other Expenses128.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income23.0M25.5M21.8M-17.7M
 
 
 
 
 
Income Taxes-4.3M-7.2M-984.0K-9.2M
 
 
 
 
 
Net Income18.7M18.3M20.8M-8.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.6M51.4M51.0M51.0M
 
 
 
 
 
Shares To Calculate EPS Diluted53.1M52.8M52.2M51.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.35$0.35$0.40-$0.17
 
 
 
 
 
EPS Diluted$0.35$0.35$0.40-$0.17